Genetic disruption of SOD1 gene causes glucose intolerance and impairs β-cell function - PubMed (original) (raw)
. 2013 Dec;62(12):4201-7.
doi: 10.2337/db13-0314. Epub 2013 Sep 5.
Adam B Salmon, Cristina Aguayo-Mazzucato, Mengyao Li, Bogdan Balas, Rodolfo Guardado-Mendoza, Andrea Giaccari, Robert L Reddick, Sara M Reyna, Gordon Weir, Ralph A Defronzo, Holly Van Remmen, Nicolas Musi
Affiliations
- PMID: 24009256
- PMCID: PMC3837066
- DOI: 10.2337/db13-0314
Genetic disruption of SOD1 gene causes glucose intolerance and impairs β-cell function
Giovanna Muscogiuri et al. Diabetes. 2013 Dec.
Abstract
Oxidative stress has been associated with insulin resistance and type 2 diabetes. However, it is not clear whether oxidative damage is a cause or a consequence of the metabolic abnormalities present in diabetic subjects. The goal of this study was to determine whether inducing oxidative damage through genetic ablation of superoxide dismutase 1 (SOD1) leads to abnormalities in glucose homeostasis. We studied SOD1-null mice and wild-type (WT) littermates. Glucose tolerance was evaluated with intraperitoneal glucose tolerance tests. Peripheral and hepatic insulin sensitivity was quantitated with the euglycemic-hyperinsulinemic clamp. β-Cell function was determined with the hyperglycemic clamp and morphometric analysis of pancreatic islets. Genetic ablation of SOD1 caused glucose intolerance, which was associated with reduced in vivo β-cell insulin secretion and decreased β-cell volume. Peripheral and hepatic insulin sensitivity were not significantly altered in SOD1-null mice. High-fat diet caused glucose intolerance in WT mice but did not further worsen the glucose intolerance observed in standard chow-fed SOD1-null mice. Our findings suggest that oxidative stress per se does not play a major role in the pathogenesis of insulin resistance and demonstrate that oxidative stress caused by SOD1 ablation leads to glucose intolerance secondary to β-cell dysfunction.
Figures
FIG. 1.
Glucose tolerance in SOD1-null mice. Blood glucose concentration was measured after the administration of intraperitoneal glucose in WT and SOD1-null mice. Data are means ± SE. *P < 0.05. KO, knockout.
FIG. 2.
Insulin-stimulated whole-body glucose disposal determined with the euglycemic-hyperinsulinemic clamp technique (A). EGP rate (B). Data are means ± SE. KO, knockout.
FIG. 3.
Insulin secretion in vivo during a hyperglycemic clamp. Data are means ± SE. *P < 0.05. KO, knockout.
FIG. 4.
Representative microscopic images of insulin, glucagon, and somatostatin immunostaining of pancreatic islets. KO, knockout.
FIG. 5.
Morphometric analysis of pancreatic islets. β-Cell volume expressed as the percentage of the pancreas (A), percentage of the islets (B), and islet size (C). Data are means ± SE. *P < 0.05. KO, knockout.
FIG. 6.
A: Average fat and lean mass for mice in the indicated diet group; *P < 0.05 between genotypes for indicated diet. B: Glucose tolerance curve in low-fat (LF) and high-fat (HF)-fed mice. C: Area under the curve calculated from glucose tolerance tests; *P < 0.05 vs. WT on low-fat diet. D: Plasma insulin concentration; *P < 0.05 vs. WT mice from corresponding diet assignment. Data are means ± SE. KO, knockout.
FIG. 7.
A: H2O2 production of isolated skeletal muscle mitochondria with different (or no) mitochondrial substrates; *P < 0.05 between genotypes for indicated diet. B: F2-isoprostanes content in muscle; *P < 0.05 vs. WT from corresponding diet. C: 4-HNE adducts in muscle; *P < 0.05 vs. WT on low-fat diet. Data are means ± SE. AU, arbitrary units; Glut/Mal, glutamate/malate; HF, high fat; KO, knockout; LF, low fat; Succ/Rot, succinate/rotenone.
References
- Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005;25:279–286 - PubMed
- Oranje WA, Wolffenbuttel BH. Lipid peroxidation and atherosclerosis in type II diabetes. J Lab Clin Med 1999;134:19–32 - PubMed
- Ogihara T, Asano T, Katagiri H, et al. Oxidative stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 2004;47:794–805 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK093909/DK/NIDDK NIH HHS/United States
- R01DK66056/DK/NIDDK NIH HHS/United States
- P01AG020591/AG/NIA NIH HHS/United States
- DK93909/DK/NIDDK NIH HHS/United States
- I01 BX000517/BX/BLRD VA/United States
- K23 AG030979/AG/NIA NIH HHS/United States
- R01 DK089229/DK/NIDDK NIH HHS/United States
- K23AG030979/AG/NIA NIH HHS/United States
- P30DK36836/DK/NIDDK NIH HHS/United States
- R01 DK066056/DK/NIDDK NIH HHS/United States
- P01 AG020591/AG/NIA NIH HHS/United States
- R01DK089229/DK/NIDDK NIH HHS/United States
- P30 DK036836/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous